Skip to content

D&A at other companies

Quest Diagnostics logo
Quest DiagnosticsDGX
$147M+5.0%
NeoGenomics logo
NeoGenomicsNEO
$8.78M-6.3%
Illumina logo
IlluminaILMN
$51M-1.9%
Veracyte logo
VeracyteVCYT
$5.43M+1.3%
Guardant Health logo
Guardant HealthGH
$9.44M-7.8%
Natera, Inc. logo
Natera, Inc.NTRA
$14.52M+57.2%

Other financials

Income statement

See full
Revenue$15.5M-24.9%
Gross profit$281.0K-96.1%
Operating income-$32.2M-81.7%
Net income-$30.0M-90.7%
EPS (diluted)-$0.29-61.1%

Balance sheet

See full
Cash & equivalents$73.6M+3.7%
Total debt$39.0M-6.2%
Total equity$254.8M+22.9%
Total assets$325.4M+19.1%

Cash flow

See full
Operating cash flow-$22.5M-25.1%
CapEx$3.2M+27.1%
Free cash flow-$25.7M-25.4%

Valuation

See full
Market cap$1.19B+110%
Enterprise value$1.16B+115%
P/S18.4×+11.8×

Profitability

See full
Gross margin13.7%-19.6pp
Operating margin-158.9%-5,457pp
Net margin-148.1%+154pp
FCF margin-131.2%-453pp

Returns & leverage

See full
Return on equity-41.4%-6.7pp
Debt / equity0.2×0.0×
Current ratio6.6×-0.3×

Where this comes from

Reported directly by Personalis, Inc. in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: Personalis, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Personalis, Inc.'s d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Personalis, Inc.'s D&A?
Personalis, Inc. (PSNL) reported D&A of $2.37M in Q1 2026.
How has Personalis, Inc.'s D&A changed year-over-year?
Personalis, Inc.'s D&A decreased by 8.3% year-over-year, from $2.59M to $2.37M.
What is the long-term trend for Personalis, Inc.'s D&A?
Over 4 years (2021 to 2025), Personalis, Inc.'s D&A has grown at a 13.6% compound annual growth rate (CAGR), from $6.02M to $10.02M.
What does D&A mean?
Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.